PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 208 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $707,000 | +14.4% | 16,250 | 0.0% | 0.04% | +5.1% |
| Q1 2019 | $618,000 | +64.4% | 16,250 | +85.7% | 0.04% | +34.5% |
| Q4 2018 | $376,000 | -12.6% | 8,750 | 0.0% | 0.03% | +20.8% |
| Q3 2018 | $430,000 | -86.5% | 8,750 | -86.9% | 0.02% | -82.4% |
| Q2 2017 | $3,196,000 | -27.0% | 67,000 | -30.2% | 0.14% | -39.0% |
| Q1 2017 | $4,378,000 | +91.8% | 96,000 | +35.8% | 0.22% | +108.4% |
| Q4 2016 | $2,283,000 | -48.0% | 70,679 | -44.9% | 0.11% | -20.1% |
| Q3 2016 | $4,393,000 | +31.3% | 128,379 | +29.4% | 0.13% | -2.2% |
| Q2 2016 | $3,346,000 | -13.1% | 99,200 | +36.5% | 0.14% | -19.4% |
| Q1 2016 | $3,852,000 | -61.3% | 72,698 | -70.0% | 0.17% | -41.6% |
| Q3 2015 | $9,965,000 | +90.0% | 242,455 | +309.9% | 0.29% | +227.0% |
| Q4 2014 | $5,244,000 | +49.5% | 59,146 | +63.4% | 0.09% | -32.1% |
| Q3 2014 | $3,508,000 | – | 36,196 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
| Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
| NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
| Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
| Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
| GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
| Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
| Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
| Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
| Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |